Why the study?
Renal dysfunction predicts poor outcomes in HFpEF, but data on novel RHC parameters of RV dysfunction such as PAPi and RA:PCWP in HFpEF are limited.
Do novel right heart catheterization parameters (PAPi and RA:PCWP) correlate with long-term renal outcomes in adult patients with HFpEF?
Do novel right heart catheterization parameters (PAPi and RA:PCWP) correlate with long-term renal outcomes in adult patients with HFpEF?
Novel right heart catheterization parameters, specifically the pulmonary artery pulsatility index (PAPi), can independently predict long-term renal dysfunction in patients with HFpEF.
No takes yet. Share an insight, caveat, or question.
May link PAPi/RA:PCWP to renal dysfunction in HFpEF; hypothesis-generating and requires prospective validation.
Lo et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: